Menu
Sign In Search Podcasts Charts People & Topics Add Podcast API Pricing
Podcast Image

Dear Menopause

86: Early Menopause and POI at 15 Years Old with Sheree Hargreaves

04 Jan 2024

Description

When Sheree Hargreaves was diagnosed with premature ovarian insufficiency at just 15, it reshaped her teenage years in unexpected ways.Sheree, now 22, shares her courageous story, navigating early menopause symptoms and the complexities of hormone replacement therapy—a narrative that will both inspire and educate. Her candid insights put a spotlight on the urgent need to bridge the education gaps in women's health, especially for conditions like POI that are often shrouded in silence.In the realm of healthcare, it's not just about the treatments—it's about understanding the human experience behind the medical charts. Sheree opens up about the mental health rollercoaster that accompanies hormone imbalances, and how she's turned her fight into fuel for advocacy and outreach. She underscores the trial-and-error journey of finding the right medication and the severe complications that can arise, driving home the importance of informed medical guidance and support for individuals with POI.Through her Instagram platform, @lifeofpoi, Sheree creates a space for connection and support, providing a source of hope and representation for others walking a similar path. Her determination to educate, advocate, and pursue a PhD is nothing short of awe-inspiring—a clear call to action for all of us to lend our voices and join the conversation on women's health.ResourcesSheree on InstagramWhat is POI? - articleDaisy Network -  A Charity for Women with POIAll The Young Men - bookSlow Horses - Apple TVThank you for listening to my show! Join the conversation on Instagram

Audio
Featured in this Episode

No persons identified in this episode.

Transcription

This episode hasn't been transcribed yet

Help us prioritize this episode for transcription by upvoting it.

0 upvotes
🗳️ Sign in to Upvote

Popular episodes get transcribed faster

Comments

There are no comments yet.

Please log in to write the first comment.